Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640

Inge Tetens

Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640

Inge Tetens

National Food Institute

Research output: Book/Report › Report

Original language	English

Publisher	European Food Safety Authority
Publication status	Published - 2010

Keywords

neurological function
fats metabolism
neuromuscular
Soy lecithin
muscle
health claims
phosphatidyl choline
glutamine
cholesterol
cognitive function

Cite this

Tetens, I. (2010). Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640. European Food Safety Authority.

Tetens, Inge. / Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640. European Food Safety Authority, 2010.

@book{81e9fddc007741ad91587d5ede77f16d,

title = "Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640",

keywords = "neurological function, fats metabolism, neuromuscular, Soy lecithin, muscle, health claims, phosphatidyl choline, glutamine, cholesterol, cognitive function",

author = "Inge Tetens",

year = "2010",

language = "English",

publisher = "European Food Safety Authority",

}

Tetens, I 2010, Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640. European Food Safety Authority.

Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640. / Tetens, Inge.

European Food Safety Authority, 2010.

Research output: Book/Report › Report

TY - RPRT

T1 - Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

T2 - EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640

AU - Tetens, Inge

PY - 2010

Y1 - 2010

KW - neurological function

KW - fats metabolism

KW - neuromuscular

KW - Soy lecithin

KW - muscle

KW - health claims

KW - phosphatidyl choline

KW - glutamine

KW - cholesterol

KW - cognitive function

M3 - Report

BT - Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

PB - European Food Safety Authority

ER -

Tetens I. Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1496 , EFSA-Q-2008-1497 , EFSA-Q-2008-2045 , EFSA-Q-2008-2332 , EFSA-Q-2008-2333 , EFSA-Q-2008-2366 , EFSA-Q-2008-2367 , EFSA-Q-2008-2694 , EFSA-Q-2008-2716 , EFSA-Q-2008-3870 , EFSA-Q-2008-3919 , EFSA-Q-2008-4959 , EFSA-Q-2008-4960 , EFSA-Q-2008-4961 , EFSA-Q-2010-00640. European Food Safety Authority, 2010.